Can I Take Vitamin B6 With Saxenda? What Women Need to Know Before Combining Them

The Short Answer: No Meaningful Interaction at Normal Doses

At the doses found in a multivitamin, B-complex, or prenatal supplement (roughly 1.9 mg to 100 mg of pyridoxine daily), vitamin B6 does not alter how your body absorbs, distributes, metabolizes, or eliminates liraglutide. Saxenda works through GLP-1 receptor agonism and is degraded by general protein catabolism pathways, not by the cytochrome P450 enzymes that vitamin B6 might theoretically influence.

The concern worth taking seriously is different: at sustained doses above 200 mg/day, vitamin B6 itself causes peripheral sensory neuropathy, a condition documented in case series and confirmed in the FDA adverse event literature. Saxenda, in rare cases, also lists peripheral neuropathy in its prescribing information. These are independent risks that happen to overlap symptomatically. Taking megadose B6 on top of Saxenda does not make neuropathy more likely through any direct drug interaction, but it does mean that if tingling or numbness appears, you and your prescriber have two possible causes to untangle instead of one.

How Saxenda Works in the Female Body

Saxenda is a GLP-1 receptor agonist approved by the FDA at 1.8 mg/day for type 2 diabetes (as Victoza) and 3 mg/day for chronic weight management in adults with a BMI of 30 or greater, or 27 or greater with a weight-related comorbidity. The approval for weight management came in 2014.

Sex-Specific Pharmacokinetics

Liraglutide's pharmacokinetics show modest sex differences. Women tend to have slightly higher peak plasma concentrations (Cmax) after subcutaneous injection compared with men at the same dose, a pattern seen across the GLP-1 class and likely explained by differences in subcutaneous tissue composition and volume of distribution. The SCALE Obesity and Prediabetes trial, which enrolled 3,731 participants and ran 56 weeks, showed women lost a mean 8.8 kg versus 7.3 kg in men on liraglutide 3 mg, though the trial was not powered to test a sex difference directly.

Hormonal Status Matters

Your hormonal environment changes how nausea, the most common GLP-1 side effect, presents and how severe it feels. Women in the luteal phase of the menstrual cycle already experience progesterone-driven gastric slowing. Starting Saxenda in the luteal phase can intensify nausea and vomiting transiently, though this has not been formally studied in a controlled trial. Women in perimenopause report overlapping symptoms (nausea, dizziness, fatigue) from estrogen fluctuations and from GLP-1 titration, making symptom attribution harder.

What Vitamin B6 Does and Why Women Take It

Pyridoxine is a water-soluble cofactor in over 100 enzymatic reactions, most of them tied to amino acid metabolism, neurotransmitter synthesis (serotonin, dopamine, GABA), and heme production. The recommended dietary allowance (RDA) for adult women is 1.3 mg/day for ages 19 to 50, rising to 1.9 mg/day in pregnancy and 2.0 mg/day while breastfeeding.

Women use B6 supplements for several reasons that frequently co-occur with weight-management treatment:

Nausea of Early Pregnancy

The ACOG Practice Bulletin on nausea and vomiting of pregnancy recommends vitamin B6 (pyridoxine) 10-25 mg three times daily as first-line pharmacologic therapy for nausea and vomiting of pregnancy. This is relevant because women of reproductive age on Saxenda for weight management before pregnancy need a clear plan: Saxenda is contraindicated in pregnancy (see dedicated section below), and B6 at these doses is safe in pregnancy on its own.

PMS and Premenstrual Dysphoric Disorder

Some women take 50-100 mg/day of B6 to ease premenstrual mood symptoms and fluid retention. A Cochrane review of B6 for PMS found doses up to 100 mg/day likely improve premenstrual and premenstrual depressive symptoms over placebo, though the review judged the trial quality as poor. This dose range is still below the threshold where neuropathy risk appears.

PCOS and Hormonal Acne

Women with polycystic ovary syndrome (PCOS) are a major demographic for Saxenda prescriptions, given that obesity and insulin resistance sit at the center of PCOS pathophysiology. Some women with PCOS self-supplement B6 for mood support or hormonal acne management, believing it modulates excess androgens. The evidence for B6 specifically in PCOS is thin, but the doses typically used (25-100 mg/day) pose no interaction concern alongside liraglutide.

B-Complex and Multivitamin Use

Multivitamins and B-complex supplements sold in the US typically contain 1.7-10 mg of B6, well inside the safe range. High-potency B-complex supplements marketed for "energy" sometimes contain 50-100 mg. These are still within the generally recognized safe upper limit.

The Real Risk: High-Dose B6 Peripheral Neuropathy

The tolerable upper intake level (UL) for vitamin B6 set by the National Academies is 100 mg/day for adults. The FDA issued a safety communication noting that sustained intakes above 200 mg/day, and sometimes lower in sensitive individuals, have been linked to sensory peripheral neuropathy characterized by tingling, burning pain, and loss of coordination in the hands and feet.

Here is a practical dose-risk framework specific to women taking Saxenda:

| B6 Daily Dose | Risk Category | Action | |---|---|---| | 1.9 to 10 mg (prenatal or multivitamin) | Negligible | No changes needed | | 11 to 100 mg (PMS dose, standard B-complex) | Low | Fine to continue; no dose separation required | | 101 to 199 mg | Moderate caution | Discuss with prescriber; monitor for tingling or numbness | | 200 mg and above | Avoid unless medically directed | Clinically documented neuropathy risk; do not combine with Saxenda without explicit guidance |

The table above does not reflect a drug-drug interaction in the pharmacological sense. Liraglutide does not alter B6 metabolism, and B6 does not alter liraglutide clearance. The concern is parallel toxicity with overlapping symptoms, not a mechanistic interaction.

Pharmacokinetic Deep Dive: Why There Is No Direct Interaction

Liraglutide is a 34-amino-acid GLP-1 analogue. It is absorbed subcutaneously with a half-life of approximately 13 hours and is degraded through endogenous protein catabolism. It does not rely on CYP1A2, CYP2D6, CYP3A4, or any other cytochrome P450 isoform for metabolism, and it is not a substrate or inhibitor of P-glycoprotein or other major drug transporters.

Pyridoxine is absorbed in the jejunum, converted to its active form pyridoxal-5-phosphate (PLP) in the liver, and excreted renally as 4-pyridoxic acid. None of these pathways intersect with liraglutide's metabolic route.

One indirect consideration: Saxenda slows gastric emptying, a class effect of GLP-1 agonists. This can theoretically delay the absorption of oral medications taken at the same time. FDA prescribing guidance for liraglutide notes this effect and recommends monitoring for drugs with narrow therapeutic windows. Vitamin B6 does not have a narrow therapeutic window. A modest delay in B6 absorption from gastric slowing is clinically irrelevant.

Pregnancy and Lactation Safety: A Required Conversation for Every Woman on Saxenda

Saxenda is contraindicated in pregnancy. This is not a theoretical caution. Liraglutide caused fetal harm in animal studies, including visceral and skeletal anomalies and reduced fetal body weight, at exposures comparable to the human dose. The FDA label assigns Saxenda a "avoid use" designation in human pregnancy, and no adequately controlled human trials in pregnant women exist.

What This Means at Each Life Stage

Reproductive years (trying to conceive or not using reliable contraception): Saxenda requires reliable contraception. If you become pregnant while on Saxenda, stop the medication and contact your prescriber and OB immediately. ACOG does not recommend GLP-1 agonists during pregnancy. Vitamin B6 at prenatal doses is safe and encouraged.

First trimester: If nausea of pregnancy begins shortly after stopping Saxenda (due to pregnancy discovery), B6 10-25 mg three times daily is the appropriate first-line treatment per ACOG Practice Bulletin 189. This B6 dose is safe and does not require any washout consideration from prior Saxenda use, because Saxenda's half-life is approximately 13 hours and it is fully cleared within a few days of stopping.

Postpartum and lactation: Liraglutide is present in rat breast milk, and the FDA label states there are no human data on liraglutide in breast milk. Given this uncertainty, Saxenda is generally not recommended during breastfeeding unless a clinician determines the benefit clearly outweighs the unknown risk. Vitamin B6 at the RDA level (2.0 mg/day while breastfeeding) is safe and present in breast milk at nutritionally appropriate concentrations. Megadose B6 above 100 mg/day during breastfeeding is not established as safe and is not recommended.

Perimenopause: Women in perimenopause using Saxenda for weight-related metabolic changes are typically not at contraceptive risk, but should confirm menopausal status with their clinician before stopping contraception. The Menopause Society (formerly NAMS) acknowledges that GLP-1 agonists are increasingly used in midlife women for metabolic weight gain, though evidence specifically in perimenopausal women remains limited.

Postmenopause: No contraceptive concern. Standard B6 supplementation alongside Saxenda is appropriate at doses within the UL.

Who This Combination Is Right For and Who Should Reconsider

Good Candidates for Standard B6 Alongside Saxenda

• Women taking a prenatal multivitamin (containing 1.9-10 mg B6) before or after pregnancy while managing weight
• Women with PCOS using 25-50 mg/day B6 for PMS alongside Saxenda for metabolic weight management
• Perimenopausal women taking a B-complex containing up to 50 mg B6 for energy or mood support
• Any woman whose total daily B6 from all sources (food plus supplements) stays below 100 mg

Women Who Should Talk to Their Prescriber First

• Women taking high-potency B-complex supplements containing 100 mg or more of B6
• Women who already have any peripheral neuropathy, whether from diabetes, chemotherapy, or another cause
• Women taking isoniazid for tuberculosis (isoniazid depletes B6, and prescribers often recommend B6 supplementation; this combination warrants explicit discussion of doses and monitoring when Saxenda is added)
• Women who notice any new tingling, numbness, or burning sensations in their hands or feet after starting either Saxenda or a new B6 supplement

Monitoring: What to Watch For

Saxenda's most common side effects are gastrointestinal: nausea (reported in up to 40% of participants in the SCALE trials), vomiting, diarrhea, and constipation. These typically peak during titration and improve after 4-8 weeks.

Peripheral neuropathy from Saxenda alone is rare and not well-characterized in the published trial data. High-dose B6 neuropathy typically appears after months of sustained intake above 200 mg/day and is usually reversible on stopping the supplement.

If you experience any of the following while on Saxenda and taking B6, report them to your prescriber and specify both agents and doses:

• Tingling, burning, or numbness in the hands, feet, or face
• Difficulty with balance or fine motor tasks
• Shooting or electric pain in the limbs

Your prescriber may order a serum pyridoxal-5-phosphate (PLP) level, nerve conduction studies, or both to determine the source.

Nutritional Context: Getting Enough B6 While Eating Less

This point rarely appears in interaction articles. Women on Saxenda eat substantially less food. The SCALE trial documented a mean reduction in daily caloric intake. Eating less means consuming less dietary B6, which is found in chicken, fish, potatoes, bananas, and fortified cereals.

A woman eating 1,200-1,400 kcal/day on Saxenda may have a dietary B6 intake of only 0.8-1.2 mg, below the RDA. A standard multivitamin or B-complex covering the RDA is therefore nutritionally appropriate for any woman on a GLP-1-based weight management plan. The American Society for Metabolic and Bariatric Surgery (ASMBS) recommends routine micronutrient supplementation for patients on medical weight management programs, and B vitamins are among those specifically mentioned.

The SCALE Obesity and Prediabetes trial enrolled participants for 56 weeks and showed that liraglutide 3 mg reduced body weight by 8.4% compared with 2.8% for placebo. Women in that trial were not systematically monitored for micronutrient deficiencies, an evidence gap worth acknowledging plainly. Micronutrient depletion in long-term GLP-1 use is under-studied, particularly in women.

A Note on Evidence Quality and What Is Extrapolated

No published randomized controlled trial has studied the combination of liraglutide 3 mg and vitamin B6 supplementation as a primary or secondary endpoint. The safety conclusions in this article are extrapolated from:

1. Liraglutide's known metabolic pathways showing no CYP450 involvement
2. B6's known absorption and excretion pathways
3. Individual safety profiles for each agent
4. Case series and mechanistic pharmacology literature on high-dose B6 neuropathy

This is an honest evidence gap. Women deserve to know when a "this is safe" claim rests on mechanistic inference rather than a head-to-head safety trial. The interaction databases consulted (Natural Medicines Comprehensive Database, which classifies the B6-liraglutide pair as "no known interaction") rely on the same mechanistic reasoning.

The takeaway: the absence of a known interaction is not the same as a proven-safe combination at all doses. At standard supplement doses, the mechanistic case for safety is strong. At megadoses, the independent toxicity of B6 is real enough that caution is warranted regardless of what Saxenda is or is not doing.

As WomanRx's reviewing clinician Maya Okafor, MD notes: "My patients on Saxenda often come in already taking five or six supplements. Vitamin B6 at prenatal or B-complex doses isn't something I lose sleep over. What I do ask about is whether they're using a high-dose B6 product for energy or PMS support without realizing how much they're actually taking. The neuropathy risk at megadoses is real and predates any GLP-1 medication. Saxenda just gives us one more reason to check the label."

Practical Steps Before Your Next Dose

1. Add up all your B6 sources: your multivitamin, your B-complex, any standalone B6 tablets, and your prenatal if applicable. Read the label. The Supplement Facts panel lists pyridoxine or vitamin B6 in milligrams.
2. If your total is below 100 mg/day, no action is needed beyond continuing your Saxenda as prescribed.
3. If your total is at or above 100 mg/day, bring the bottles to your next telehealth visit and ask your prescriber or RD to review the doses.
4. If you notice any peripheral tingling or numbness at any B6 dose, report it the same day. Do not assume it is unrelated.
5. If you are planning a pregnancy, stop Saxenda, start folic acid at 400-800 mcg/day, and confirm appropriate B6 dosing (the prenatal-level dose, not a high-potency standalone) with your OB or midwife.

The FDA Saxenda prescribing information lists no supplement interactions requiring mandatory separation intervals. A standard prenatal or multivitamin can be taken at any time relative to your Saxenda injection.